Latest News
BioStem Technologies, Inc.
- BioStem Technologies, Inc. SEC Filing (Oct 13, 2026)
- BioStem Technologies (Nasdaq:BSEM) - Stock Analysis
- At $2 a share, BioStem Technologies (BSEM) CEO exercised options for 250,000 shares.
- At $2 a share, BioStem Technologies (BSEM)'s COO exercises options to acquire 250,000 shares.
- BioStem Technologies CEO and COO Invest $1 Million Through Stock Option Exercises
- BioStem Technologies’ CEO and COO invest $1M in cash through exercise of stock options
- BioStem CEO and COO invest $1M by exercising st...
- BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
- BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
- BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Nothing remains to be sold in BioStem Technologies (BSEM)'s equity offering.
Headlines from the last 30 days, linking to the original publishers. See all market news →